Polypill with or without Aspirin in Persons without Cardiovascular Disease

2020261 citationsJournal Articlebronze Open Access

Authors

Salim Yusuf · Population Health Research Institute

Philip Joseph · Population Health Research Institute

Antonio Dans · Population Health Research Institute

Peggy Gao · Population Health Research Institute

Koon Teo · Population Health Research Institute

Denis Xavier · Population Health Research Institute

Patricio López‐Jaramillo

Abstract

Combined treatment with a polypill plus aspirin led to a lower incidence of cardiovascular events than did placebo among participants without cardiovascular disease who were at intermediate cardiovascular risk. (Funded by the Wellcome Trust and others; TIPS-3 ClinicalTrials.gov number, NCT01646437.).

Topics & Keywords

Medication Adherence and Compliance Pharmaceutical Economics and Policy Diabetes Treatment and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 384, Issue 3, pp. 216-228

DOI: 10.1056/nejmoa2028220

Field-Weighted Citation Impact: 35.02